Status:
UNKNOWN
China Pituitary Disease Registry (CAPASITY)
Lead Sponsor:
Shanghai Jiao Tong University School of Medicine
Conditions:
Pituitary Disease
Eligibility:
All Genders
14-75 years
Brief Summary
Epidemiologic studies have revealed a tremendous increase in the prevalence of pituitary disease and related mortality worldwide. In order to meet all the challenges in the treatment of pituitary dise...
Detailed Description
In order to meet all the challenges in the diagnosis and treatment of pituitary diseases in China, CAPASITY was founded in 2020. With advanced medical equipment and Internet of Things (IoT) technology...
Eligibility Criteria
Inclusion
- Age ≥ 18 years old and ≤ 75 years
- Patients diagnosed with pituitary adenomas, and other pituitary diseases
- Pituitary adenomas resected by transsphenoidal surgery were identified by histological diagnoses.
- Gender: males and females
- Provide written informed consent
- Satisfactory compliance
Exclusion
- Patients with significantly reduced life expectancy (less than 2 years)
- With Drug abuse
- With AIDS or syphilis or infectious diseases such as viral tuberculosis in active phase at enrollment
Key Trial Info
Start Date :
July 26 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT04713293
Start Date
July 26 2020
End Date
December 31 2025
Last Update
January 19 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Metabolic Management center
Shanghai, Shanghai Municipality, China, 200025